Taking a comprehensive and integrative approach to the assessment and treatment of brain-based dysfunction, the Neuropsychiatric Center of Chicago at Hartgrove challenges traditional viewpoints of mental health disorders. Our team of experts helps patients understand that the origin of their emotions, behaviors and thoughts begin in the brain. Through the use of neuroimaging, the team is able to identify areas of the brain that are malfunctioning and connect them to specific impairments in emotions, behaviors and thoughts. This reconceptualization helps to diminish the stigma that is so frequently associated with mental illness.
Recognized by The Joint Commission for its innovative treatment of brain-based disorders, the Neuropsychiatric Center received the first Disease-specific Certification designation in the nation. By utilizing cutting-edge technology, the award-winning program identifies and addresses the neurobiological origin of emotional and behavioral problems that are commonly associated with disorders such as:
- Traumatic brain injuries (TBI) – mild to moderate severity
- Seizure disorders/epilepsy
- Patients exposed to drugs in-utero
- Attention Deficit Hyperactivity Disorders (ADHD)
- Closed-head and sports-related injuries/concussions
- Treatment-resistant depression
- Bipolar and anxiety disorders
- Other physical and chemical brain dysfunctions
The foundation of the Neuropsychiatric Center’s treatment approach is QEEG (quantitative electroencephalogram) testing. Rather than relying on patient self-report and behavioral observations, QEEG provides an objective and detailed picture of the brain’s activity. Test results provide the treatment team with valuable information regarding the region of the brain that presents with dysfunction and allows for targeted medication intervention. Much like the electrodes used in an EKG (electrocardiogram) that tests the electrical activity of your heart, a similar process is used through QEEG. With electrodes placed in targeted regions on the patient’s head, electrical activity in the brain is measured. The process is noninvasive and allows the brain dysfunction to be identified and treated more quickly.
After QEEG testing, a uniquely tailored neuropsychological evaluation is administered. This evaluation combined with the QEEG test complete an accurate clinical picture of each patient by assisting with differential diagnosis, identification of impairments in memory, concentration, attention and executive functioning. Treatment recommendations can then be made to allow the patient to thrive at home, at work and in school settings.